Cochlear disagrees with new competition concerns over takeover
Hearing implant manufacturer Cochlear has again rebuffed competition concerns from authorities over its planned takeover of competitor Oticon Medical for $170 million, which followed a decision by parent company Demant to exit the hearing implants business. Cochlear said it disagreed with the conclusions of the UK Competition and Markets Authority (CMA) which found provisionally that…
Details